Frederick S. Ling, M.D. is an Associate Professor of medicine in the Cardiology Unit and Director of the Cardiac Catheterization Laboratory. He joined the faculty in 1993 after training at Yale University in both cardiovascular medicine and interventional cardiology. Dr. Ling specializes in all aspects of interventional cardiology in the evaluation and treatment of coronary artery disease.
Under his direction, the Cardiac Catheterization Laboratory currently consists of four labs, but is undergoing expansion. All angiographic studies are now digitally archived and networked for immediate access and review. A computerized reporting system with a central database tracks patients for data collection and research. The Cardiac Catheterization Laboratory also has been at the core of Strong Memorial Hospital's successful clinical program to treat acute myocardial infarction by primary angioplasty or stenting.
Education / Certification
M.D., New York University School of Medicine - 1986
Resident, Beth Israel Hospital - 1986-89
Clinical Fellow, Yale-New Haven Hospital - 1989-91
Research Fellow, Yale-New Haven Hospital - 1991-1992
Fellow, Yale-New Haven Hospital - 1992-1993
Research and Professional Experience
University of Rochester School of Medicine and Dentistry, Assistant Professor of Medicine/Cardiology - 1993-2000
University of Rochester School of Medicine and Dentistry, Associate Professor of Medicine/Cardiology - 2000-Present

• Qian F, Ling FS, Deedwania P, Hernandez AF, Fonarow GC, Cannon CP, Peterson ED, Peacock WF, Kaltenbach LA, Laskey WK, Schwamm LH, Bhatt DL. Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program. Circ Cardiovasc Qual Outcomes. 2012 Jan 1; 5(1):126-33.
  View in: PubMed
• Qian F, Hannan EL, Glance LG, Phelps CE, Ling FS, Veazie PJ. Coronary stent use in New York State in the drug-eluting stent era. J Eval Clin Pract. 2012 Aug; 18(4):872-7.
  View in: PubMed
• Aktas MK, Kroening D, Ling FS, Calkins H, Goldenberg I, Huang DT. A 61-year-old patient with activity-related wide complex tachycardia. Ann Noninvasive Electrocardiol. 2011 Apr; 16(2):208-12.
  View in: PubMed
• Qian F, Phelps CE, Ling FS, Hannan EL, Veazie PJ. Attitudes towards drug-eluting stent use and the distribution of motivation type among interventional cardiologists. J Eval Clin Pract. 2012 Jun; 18(3):528-33.
  View in: PubMed
• Russo RJ, Silva PD, Teirstein PS, Attubato MJ, Davidson CJ, DeFranco AC, Fitzgerald PJ, Goldberg SL, Hermiller JB, Leon MB, Ling FS, Lucisano JE, Schatz RA, Wong SC, Weissman NJ, Zientek DM. A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial). Circ Cardiovasc Interv. 2009 Apr; 2(2):113-23.
  View in: PubMed
• Le MQ, Ling FS. Spontaneous dissection of the left main coronary artery treated with percutaneous coronary stenting. J Invasive Cardiol. 2007 Aug; 19(8):E218-21.
  View in: PubMed
• Nguyen N, Hasan S, Caufield L, Ling FS, Narins CR. Randomized controlled trial of topical hemostasis pad use for achieving vascular hemostasis following percutaneous coronary intervention. Catheter Cardiovasc Interv. 2007 May 1; 69(6):801-7.
  View in: PubMed
• Montalescot G, White HD, Gallo R, Cohen M, Steg PG, Aylward PE, Bode C, Chiariello M, King SB, Harrington RA, Desmet WJ, Macaya C, Steinhubl SR. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med. 2006 Sep 7; 355(10):1006-17.
  View in: PubMed
• Narins CR, Ling FS, Fischi M, Peterson DR, Bausch J, Zareba W. In-hospital mortality among women undergoing contemporary elective percutaneous coronary intervention: a reexamination of the gender gap. Clin Cardiol. 2006 Jun; 29(6):254-8.
  View in: PubMed
• Narins CR, Dozier AM, Ling FS, Zareba W. The influence of public reporting of outcome data on medical decision making by physicians. Arch Intern Med. 2005 Jan 10; 165(1):83-7.
  View in: PubMed
• Cutlip DE, Ricciardi MJ, Ling FS, Carrozza JP, Dua V, Garringer J, Giri S, Caputo RP. Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction. Am J Cardiol. 2003 Oct 15; 92(8):977-80.
  View in: PubMed
• King KB, Quinn JR, Delehanty JM, Rizzo S, Eldredge DH, Caufield L, Ling FS. Perception of risk for coronary heart disease in women undergoing coronary angiography. Heart Lung. 2002 Jul-Aug; 31(4):246-52.
  View in: PubMed
• Kalaria VG, Chaudhary I, Jacobson S, Pomerantz RM, Cove CJ, Ling FS, Cutlip DE. Evolution in the practice of primary angioplasty: effect of adjunctive coronary stenting and glycoprotein IIb/IIIa inhibitors on long-term outcomes. Catheter Cardiovasc Interv. 2001 Nov; 54(3):327-32.
  View in: PubMed
• Harb TS, Ling FS. Inadvertent stent extraction six months after implantation by an entrapped cutting balloon. Catheter Cardiovasc Interv. 2001 Jul; 53(3):415-9.
  View in: PubMed
• Cutlip DE, Cove CJ, Irons D, Kalaria V, Le M, Cronmiller H, Caufield L, Pomerantz RM, Ling FS. Emergency room administration of eptifibatide before primary angioplasty for ST elevation acute myocardial infarction and its effect on baseline coronary flow and procedure outcomes. Am J Cardiol. 2001 Jul 1; 88(1):A6, 62-4.
  View in: PubMed
• Kalaria VG, Ling FS. Late stent thrombosis without antecedent brachytherapy: confirmation and treatment with rheolytic thrombectomy. Catheter Cardiovasc Interv. 2001 Jun; 53(2):243-7.
  View in: PubMed
• Kalaria VG, Mendelsohn A, Peterson J, Ling FS. Double-chambered right ventricle in an adult patient. J Invasive Cardiol. 2001 Feb; 13(2):111-3.
  View in: PubMed
• King KB, Quinn JR, Delehanty JM, Rizzo S, Eldredge DH, Caufield L, Ling FS. Reasons for use of hormone replacement therapy in women undergoing coronary angiography. J Womens Health Gend Based Med. 2000 Dec; 9(10):1081-7.
  View in: PubMed
• Mendelsohn AM, Buzzard CJ, Lerner NB, Ling FS. Transumbilical balloon angioplasty of subclavian artery thrombosis in a neonate. Catheter Cardiovasc Interv. 2000 Jan; 49(1):56-60.
  View in: PubMed
• Skulski R, Snider JM, Buzzard CJ, Ling FS, Mendelsohn AM. Transcatheter closure of a patent foramen ovale following mitral valve replacement. Ann Thorac Surg. 1999 Aug; 68(2):582-3.
  View in: PubMed
• Delehanty JM, Ling FS, Berk BC. If I had an acute coronary syndrome... Lancet. 1999 Jun; 353 Suppl 2:SII24-6.
  View in: PubMed
• Chu TN, Ling FS. Successful management of Palmaz-Schatz stents deformed by inadvertent angioplasty outside the stents. Cathet Cardiovasc Diagn. 1997 Aug; 41(4):435-9.
  View in: PubMed
• Pomerantz RM, Ling FS. Distortion of Palmaz-Schatz stent geometry following side-branch balloon dilation through the stent in a rabbit model. Cathet Cardiovasc Diagn. 1997 Apr; 40(4):422-6.
  View in: PubMed
• Stuver TP, Ling FS. The "furrowing effect": guidewire-induced "directional" lesion ablation in rotational atherectomy of angulated coronary artery lesions. Cathet Cardiovasc Diagn. 1996 Dec; 39(4):385-95.
  View in: PubMed
• Jaffar A, Cunningham MJ, Ling FS. Transcatheter aspiration of atheroma prolapsing through saphenous vein graft stents. Cathet Cardiovasc Diagn. 1996 Nov; 39(3):258-61.
  View in: PubMed
• Cusco JA, Delehanty JM, Ling FS. Trifurcation triple balloon angioplasty in a dual left anterior descending coronary artery: the "Ménage à trois" revisited. Cathet Cardiovasc Diagn. 1996 Jun; 38(2):214-7.
  View in: PubMed